Clinical Trials Browser

Phase 2 × Has announcements × Nasopharyngeal Carcinoma × Clear all

NCT03866967 2025-02-27

A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

130 enrolled 1 FDA

Nasopharyngeal Carcinoma